ProstaGene

Video: Dr Pestell receives award from Komen Foundation for new treatment of cancer metastasis

http://prostagene.com/video-dr-pestell-receives-award-from-komen-foundation-for-new-treatment-of-cancer-metastasis/

Video: Dr Pestell receives award from Komen Foundation for new treatment of cancer metastasis More Than Kickoff – CBS3 Early   More Than Kickoff – CBS3 Night

ProstaGene was assigned important patents for cancer treatment. US Patent issued September 27, 2016 as U.S. Patent No. 9,453,836. “Use of modulators of CCR5 in the treatment of cancer and cancer metastasis” US Provisional Patent Application Nos. 61/646,593 and 61/646,586 (Reference Nos. 010236-5002-PR & 010236-5002-PR1)

http://prostagene.com/prostagene-assigned-new-patents-in-cancer-treatment/

ProstaGene assigned new patents in cancer treatment ProstaGene was assigned important patents for cancer treatment. US Patent issued September 27, 2016 as U.S. Patent No. 9,453,836. “Use of modulators of CCR5 in the treatment of cancer and cancer me…

New Team Member: David T. Bonk

http://prostagene.com/david-t-bonk/

David T. Bonk David brings 30 years of experience in the biopharmaceutical industry, and has served as: Chair of the PhRMA Law Section. The global head lawyer at Bristol-Myers Squibb in three different practice ...